Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.69
0.0000
Volume:11
Turnover:318.41
Market Cap:1.00M
PE:- -
High:28.69
Open:28.69
Low:28.69
Close:28.69
52wk High:29.88
52wk Low:24.32
Shares:35.00K
Float Shares:35.00K
Volume Ratio:0.03
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Estée Lauder Exec VP, General Counsel Rashida La Lande Sells 5,564 Shares for $553,695.4

Reuters
·
Aug 26

China's Shandong Xinhua Profit Drops on Domestic, International Competition

Reuters
·
Aug 25

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Reuters
·
Aug 25

Austar Lifesciences H1 Profit Drops on Higher R&D Spending

Reuters
·
Aug 25

WuXi Biologics H1 Net Profit up on Margin Expansion

Reuters
·
Aug 25

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Aug 25

Molecular Partners H1 Net Loss Narrows on Lower R&D Expenses

Reuters
·
Aug 25

Inside a Jinan Factory: How One Chinese Beauty Maker Is Targeting Global Consumers

Deep News
·
Aug 25

Oruka Therapeutics Names Todd Edwards Chief Commercial Officer

Reuters
·
Aug 25

Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating

MT Newswires Live
·
Aug 25

Is AbbVie (ABBV) Fairly Valued As New Lung Cancer Data Impresses?

Simply Wall St.
·
Aug 25

Hims & Hers’ weight-loss plans draw penalties by Visa, Bloomberg reports

TIPRANKS
·
Aug 24

ANI Pharma Appoints Henry Gosebruch to Board of Directors

Reuters
·
Aug 24

EstÉE Lauder : Berenberg Raises Target Price to $92 from $84

THOMSON REUTERS
·
Aug 24

Hims & Hers (HIMS) Stock Looks Like A Bargain After A 396% Run

Simply Wall St.
·
Aug 23

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

TIPRANKS
·
Aug 22

Market Chatter: Hims & Hers Health Faces Nearly $75,000 Bill From Card Disputes

MT Newswires Live
·
Aug 22

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

TIPRANKS
·
Aug 22

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TIPRANKS
·
Aug 22